BioCryst Pharmaceuticals, Inc. (BCRX): Price and Financial Metrics
BioCryst Pharmaceuticals, Inc. (BCRX)
Today's Latest Price: $5.43 USD
0.09 (-1.63%)
Updated Jul 10 4:00pm
Add BCRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BCRX Stock Summary
- Biocryst Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 97.43% of US listed stocks.
- BCRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.59% of US stocks.
- As for revenue growth, note that BCRX's revenue has grown 111.71% over the past 12 months; that beats the revenue growth of 94.96% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Biocryst Pharmaceuticals Inc, a group of peers worth examining would be LXRX, STX, HALO, STRO, and TNAV.
- Visit BCRX's SEC page to see the company's official filings. To visit the company's web site, go to www.biocryst.com.
BCRX Daily Price Range
BCRX 52-Week Price Range
BCRX Stock Price Chart Technical Analysis Charts
BCRX Price/Volume Stats
| Current price | $5.43 | 52-week high | $6.29 |
| Prev. close | $5.53 | 52-week low | $1.38 |
| Day low | $5.24 | Volume | 5,610,965 |
| Day high | $5.60 | Avg. volume | 8,304,291 |
| 50-day MA | $4.66 | Dividend yield | N/A |
| 200-day MA | $3.16 | Market Cap | 957.86M |
BioCryst Pharmaceuticals, Inc. (BCRX) Company Bio
Biocryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in rare diseases. The company was founded in 1986 and is based in Durham, North Carolina.
Loading social stream, please wait...